Joint Formulary & PAD

Palivizumab - RSV prophylaxis

You are here : Home > Formulary Search > Palivizumab - RSV prophylaxis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Injection
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
NHSE
NICE
R
SPC
Restrictions / Comments :
Important

restricted antimicrobial for paediatric use, to be used on the advice of microbiologist 

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Palivizumab
Indication :
RSV prophylaxis
Group Name :
Keywords :
respiratory syncytial virus
Brand Names Include :
Synagis
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Committee Recommendations (1)

07 Aug 24 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.

Other Indications

Below are listed other indications that Palivizumab is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat RSV prophylaxis.

  • No records returned.